Premiere: A global commercial for Kaloba®

Kaloba ist ein Erkältungspräparat der Schwabe-Gruppe

A true premiere: For the first time in Schwabe history, we have created a commercial for one of our brands that is designed for a global audience. The new Kaloba® TV commercial will make its way across the small screen in Austria, the Czech Republic, Italy, Slovakia and Bulgaria in time for the 2023 cold season.  

New milestone reached in our understanding of the mechanism of action of EPs® 7630!

Stethoscope on cardiogram

Two recently published preclinical studies boost the understanding of the potential mechanism of action of the Pelargonium sidoides extract EPs® 7630 in connetcion with Rhinovirusinfektion und SARS-CoV-2 and show the benefit of joint research projects with academia in the area of phytopharmaceuticals.  

Kaloba® awarded with “Empowered By Evidence” seal!

Empowered by evidence seal

Our preparation Kaloba® has been awarded the "Empowered By Evidence" seal by the Natural Health Science Foundation. Kaloba® is thus the only "Empowered By Evidence"-certified product in the world to date for respiratory infections. 

Schwabe Group Germany greatly reduces CO2 emissions!

Road sign with decreasing CO2 emissions

In 2022, the Schwabe Group successfully made major reductions in its CO2 emissions for Scope 1 and 2 in Germany versus the previous year’s figures. Interim data about the carbon footprint in Germany are now available and confirm this trend,

Dr. Willmar Schwabe Young Talent Prize goes to Dr. Adriano Rutz!

Dr. Dirk Bredenbröker, Dr. Antonio Rutz and Dr. Judith Rollinger during the award ceremony of the Dr. Willmar Schwabe Young Talent Prize

Dr. Adriano Rutz, a researching pharmacist at the ETH Zurich, was awarded with the Dr. Willmar Schwabe Young Talent Prize for his outstanding contribution: he established a platform called the Lotus Initiative which is designed to share data about natural products and their origins.

German Federal Ministry honors the Schwabe Group with research seal!

German Federal Ministry honors the Schwabe Group with research seal

In recent years, our department for reserach and development successfully qualified for financial support for a number of projects as part of the German research-subsidy law. And now the Federal Ministry of Education and Research has awarded us the seal which certifies us as an official reserach and development company.

Irish Minister for Enterprise Trade and Employment Coveney visits headquarters

Minister Simon Coveney and Irish delegation visiting the Schwabe Group

On Tuesday, the Irish Minister for Enterprise, Trade and Employment, Simon Coveney, visited the Schwabe Group headquarters together with the Irish Ambassador to Germany Nicholas O'Brien and Mary Buckley, Executive Director of the IDA. 

Review of clinical trials confirms efficacy of EGb 761®

Stethoscope on cardiogram

A systematic review of 9 placebo-controlled clinical trials confirmed the efficacy of Ginkgo biloba extract EGb 761®. Significant effects were demonstrated in particular in the cognitive areas of memory, information processing, attention as well as planning and mental flexibility.

Schwabe Group Switzerland to launch Refluctan®

Packshot Refluctan

New Refluctan® chewable tablets have twice the effect on heartburn: the mineral-based acid buffers quickly soothe acid-related gastric discomfort such as heartburn and acid regurgitation. At the same time, the highly concentrated ingredients from herbal prickly pear extract naturally calm and protect the mucous membrane of the oesophagus.

14.02.2023 - A clinical trial assessed the use of EPs® 7630 as Syrup and Solution in children ages one to five with acute bronchitis. The study found that an improvement in health status and complaints were comparably positive in treatment with EPs® 7630. Both dosage forms were equally safe and well-tolerated in children between the ages of one and five.  


26.01.2023 - In 2022, the Schwabe Group Germany converted to green electricity at both of its sites in Karlsruhe. This means that all of the electricity obtained from our power supplier comes from renewable kinds of energy. 


15.01.2023 - We are pleased to announce a new research agreement with Dalhousie University from Nova Scotia, Canada. In conjunction with Prof. Vasantha Rupasinghe, one of the leading experts in the field of research about the haskap berry, we will analyze novel extraction methods for producing a special extract with enriched active substances (cyanidin-3-glucoside).


05.12.2022 - We are pleased to announce that our high-quality pharmaceutical Refluthin® was launched in Belgium. New Refluthin® chewable tablets have twice the effect on heartburn: the mineral-based acid buffers quickly soothe acid-related gastric discomfort such as heartburn and acid regurgitation.


21.11.2022 - Our Web Content Management System (WCMS) is one of the winners of this year's SplashAwards. In the category "Healthcare", the Schwabe Group came out as the best Drupal project..


16.11.2022 - Schwabe Group Germany received an award this year once again for its commitment to offering professional training! The business magazine Capital gave us full marks in the fields of mentorship, innovative teaching methods, and excellent future prospects!


13.10.2022 - For over 10 years Nature’s Way has been quietly supporting Feed the Children – a non-profit organization which envisions a world in which no child goes to bed hungry.


16.09.202 - The Dr Willmar Schwabe Award, which is sponsored by our company, was first presented by the GA – Society for Medicinal Plant and Natural Product Research, one of the world’s most important scientific societies in phytoresearch, back in 1961. This year Dr Simone Moser from Ludwig Maximilian University of Munich, was awarded for her innovative and pioneering research.


14.09.2022 - At the 39th Annual Healthcare Advertising Award ceremony, Schwabe’s explainer video on the topic of mild cognitive impairment (MCI) won over the jury and brought home a Merit Award.


25.08.2022 - The Pegaso® line consists of probiotics, prebiotics, herbal ingredients and vitamins, and it represents a distinctive therapeutic approach to specific GI complaints (diarrhea, constipation, etc.). At the same time, it is ideal for treating a variety of problems in children and adults.


29.07.2022 - In a recent review, Bartova et al.* present findings that Silexan® has beneficial effects also on co-occurring depressive symptoms in patients with underlying anxiety and anxiety disorders. The data were collected from patients with anxiety in several clinical trials and have now been recompiled and statistically analyzed. 


08.06.2022 - As part of the Schwabe Phyto Innovation Challenge, we are pleased to announce a new research agreement with the department of pharmacognosy at the University of Vienna. Under the guidance of chair Dr. Judith M. Rollinger, we will spend the next three years working on a joint project to analyze the positive effects of herbal extracts and combinations of natural substances on age-related diseases.




07.07.2022 - As part of the Schwabe Phyto Innovation Challenge, we have now successfully launched a collaborative project: Dr. Simone Moser and her team will analyze phylloxanthobilins; this group of substances was discovered in recent years and is thought to have potentially positive effects on arteriosclerosis. The process of the blood vessels hardening is responsible for the majority of cardiovascular problems in older people.


13.04.2022 - We are pleased to announce that our high-quality pharmaceutical Gaspan® was launched in Italy. Recurrent or persistent gastrointestinal complaints such as flatulence, mild cramps and a feeling of fullness impair quality of life. Gaspan® works with a unique combination of peppermint oil and caraway oil and has a targeted effect where the discomfort is caused: in the gut.